Bile acid induced gene expression in LT97 colonic adenoma cells

Food and Chemical Toxicology

Volumn 43, Issue 1, 2005, Pages 87-93

  Jurek, Daniela ^a   Fleckl, Elisabeth ^a   Marian, Brigitte ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

ACF, aberrant crypt foci; CDC, chenodesoxycholate; COX, cyclooxygenase; DOC, desoxycholate; GCDC, glycochenodesoxycholate; LDC, lithodesoxycholic acid; PGE2, prostaglandin E2; T0DOC, taurodesoxycholate; TGF , transforming growth factor

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CYCLOOXYGENASE 2; DEOXYCHOLIC ACID; PROTEIN C FOS; TAURODEOXYCHOLIC ACID; VASCULOTROPIN;

ARTICLE; CARCINOGENESIS; CELL STIMULATION; CELL STRAIN; COLON ADENOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; GENE INDUCTION; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; MARKER GENE; PROTEIN EXPRESSION; UPREGULATION;

ADENOMA; BILE ACIDS AND SALTS; CELL LINE, TUMOR; CHENODEOXYCHOLIC ACID; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; DEOXYCHOLIC ACID; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; POLYMERASE CHAIN REACTION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTO-ONCOGENE PROTEINS C-FOS; RNA; TAURODEOXYCHOLIC ACID; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 9644295725     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2004.08.015     Document Type: Article

References (37)

1. P.K. Baijal, E.P. Clow, D.W. Fitzpatrick, and R.P. Bird Tumor-enhancing effects of cholic acid are exerted on the early stages of colon carcinogenesis via induction of aberrant crypt foci with an enhanced growth phenotype Can. J. Physiol. Pharmacol. 76 1998 1095 1102
2. P.K. Baijal, D.W. Fitzpatrick, and R.P. Bird Comparative effects of secondary bile acids, deoxycholic and lithocholic acids, on aberrant crypt foci growth in the postinitiation phases of colon carcinogenesis Nutr. Cancer 31 1998 81 89
3. F.L. Chung, C.C. Conaway, C.V. Rao, and B.S. Reddy Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate Carcinogenesis 21 2000 2287 2291
4. R.J. Coffey, C.M. McCutchen, R. Graves-Deal, and W.H. Polk Jr. Transforming growth factors and related peptides in gastrointestinal neoplasia J. Cell Biochem. Suppl. 16G 1992 111 118
5. C.L. Crowley-Weber, C.M. Payne, M. Gleason-Guzman, G.S. Watts, B. Futscher, C.N. Waltmire, C. Crowley, K. Dvorakova, C. Bernstein, M. Craven, H. Garewal, and H. Bernstein Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate Carcinogenesis 23 2002 2063 2080
6. R. Di Toro, G. Campana, G. Murari, and S. Spampinato Effects of specific bile acids on c-fos messenger RNA levels in human colon carcinoma Caco-2 cells Eur. J. Pharm. Sci. 11 2000 291 298
7. C.E. Eberhart, R.J. Coffey, A. Radhika, F.M. Giardiello, S. Ferrenbach, and R.N. DuBois Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1994 1183 1188
8. E.A. Friedman Differential response of premalignant epithelial cell classes to phorbol ester tumor promoters and to deoxycholic acid Cancer Res. 41 1981 4588 4599
9. B. Glinghammar, H. Inoue, and J.J. Rafter Deoxycholic acid causes DNA damage in colonic cells with subsequent induction of caspases, COX-2 promoter activity and the transcription factors NF-kB and AP-1 Carcinogenesis 23 2002 839 845
10. O. Habel, L. Bertario, S. Andreola, G. Sirizzotti, and B. Marian Tissue localization of TGFalpha and apoptosis are inversely related in colorectal tumors Histochem. Cell Biol. 117 2002 235 241
11. Y. Hirose, T. Kuno, Y. Yamada, K. Sakata, M. Katayama, K. Yoshida, Z. Qiao, K. Hata, N. Yoshimi, and H. Mori Azoxymethane-induced beta-catenin- accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis Carcinogenesis 24 2003 107 111
12. J.A. Lapre, H.T. De Vries, D.S. Termont, J.H. Kleibeuker, E.G. De Vries, and R. Van der Meer Mechanism of the protective effect of supplemental dietary calcium on cytolytic activity of fecal water Cancer Res. 53 1993 248 253
13. D.J. MacGregor, Y.S. Kim, M.H. Sleisenger, and L.K. Johnson Chemoprevention of colon cancer carcinogenesis by balsalazide: inhibition of azoxymethane-induced aberrant crypt formation in the rat colon and intestinal tumor formation in the B6-Min/+ mouse Int. J. Oncol. 17 2000 173 179
14. N. Metz, A. Lobstein, Y. Schneider, F. Gosse, R. Schleiffer, R. Anton, and F. Raul Suppression of azoxymethane-induced preneoplastic lesions and inhibition of cyclooxygenase-2 activity in the colonic mucosa of rats drinking a crude green tea extract Nutr. Cancer 38 2000 60 64
15. Y. Miyagi, A.S. Om, K.M. Chee, and M.R. Bennink Inhibition of azoxymethane-induced colon cancer by orange juice Nutr. Cancer 36 2000 224 229
16. M. Morotomi, Y. Sakaitani, M. Satou, T. Takahashi, A. Takagi, and M. Onoue Effects of a high-fat diet on azoxymethane-induced aberrant crypt foci and fecal biochemistry and microbial activity in rats Nutr. Cancer 27 1997 84 91
17. T. Narisawa, M. Takahashi, M. Niwa, Y. Fukaura, and A. Wakizaka Involvement of prostaglandin E2 in bile acid-caused promotion of colon carcinogenesis and anti-promotion by the cyclooxygenase inhibitor indomethacin Jpn. J. Cancer Res. 78 1987 791 798
18. M. Oshima, J.E. Dinchuk, S.L. Kargman, H. Oshima, B. Hancock, E. Kwong, J.M. Trzaskos, J.F. Evans, and M.M. Taketo Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 87 1996 803 809
19. L.P. Peiffer, D.J. Peters, and T.J. McGarrity Differential effects of deoxycholic acid on proliferation of neoplastic and differentiated colonocytes in vitro Dig. Dis. Sci. 42 1997 2234 2240
20. C.V. Rao, Y. Hirose, C. Indranie, and B.S. Reddy Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids Cancer Res. 61 2001 1927 1933
21. B.S. Reddy, Y. Hirose, R. Lubet, V. Steele, G. Kelloff, S. Paulson, K. Seibert, and C.V. Rao Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis Cancer Res. 60 2000 293 297
22. B.S. Reddy, K. Watanabe, J.H. Weisburger, and E.L. Wynder Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats Cancer Res. 37 1977 3238 3242
23. B.S. Reddy, and E.L. Wynder Metabolic epidemiology of colon cancer. Fecal bile acids and neutral sterols in colon cancer patients and patients with adenomatous polyps Cancer 39 1977 2533 2539
24. M. Richter, D. Jurek, F. Wrba, K. Kaserer, G. Wurzer, J. Karner Hanusch, and B. Marian Cells obtained from colorectal microadenomas mirror early premalignant growth patterns in vitro Eur. J. Cancer 38 2002 1937 1945
25. M. Richter, M. Weiss, I. Weinberger, G. Furstenberger, and B. Marian Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors Carcinogenesis 22 2001 17 25
26. R. Schulte-Hermann, B. Marian, and W. Bursch Tumor Promotion H. Marquart G.G. Schäfer R.O. McClellan F. Welsch Toxicology 1999 Academic Press San Diego 179 215
27. H. Seno, M. Oshima, T.O. Ishikawa, H. Oshima, K. Takaku, T. Chiba, S. Narumiya, and M.M. Taketo Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps Cancer Res. 62 2002 506 511
28. B. Shpitz, Y. Bomstein, Y. Mekori, R. Cohen, Z. Kaufman, D. Neufeld, M. Galkin, and J. Bernheim Aberrant crypt foci in human colons: distribution and histomorphologic characteristics Hum. Pathol. 29 1998 469 475
29. J. Singh, R. Hamid, and B.S. Reddy Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer Cancer Res. 57 1997 253 258
30. S.A. Stopera, J.R. Davie, and R.P. Bird Colonic aberrant crypt foci are associated with increased expression of c-fos: the possible role of modified c-fos expression in preneoplastic lesions in colon cancer Carcinogenesis 13 1992 573 578
31. L.A. Sutherland, and R.P. Bird The effect of chenodeoxycholic acid on the development of aberrant crypt foci in the rat colon Cancer Lett. 76 1994 101 107
32. M. Takahashi, M. Mutoh, T. Kawamori, T. Sugimura, and K. Wakabayashi Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis Carcinogenesis 21 2000 1319 1327
33. T. Takayama, S. Katsuki, Y. Takahashi, M. Ohi, S. Nojiri, S. Sakamaki, J. Kato, K. Kogawa, H. Miyake, and Y. Niitsu Aberrant crypt foci of the colon as precursors of adenoma and cancer New Engl. J. Med. 339 1998 1277 1284
34. T. Tanaka, H. Kohno, M. Murakami, R. Shimada, S. Kagami, T. Sumida, Y. Azuma, and H. Ogawa Suppression of azoxymethane-induced colon carcinogenesis in male F344 rats by mandarin juices rich in beta-cryptoxanthin and hesperidin Int. J. Cancer 88 2000 146 150
35. T. Tanaka, H. Kohno, R. Shimada, S. Kagami, F. Yamaguchi, S. Kataoka, T. Ariga, A. Murakami, K. Koshimizu, and H. Ohigashi Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats Carcinogenesis 21 2000 1183 1189
36. S. Untawale, M.A. Zorbas, C.P. Hodgson, R.J. Coffey, G.E. Gallick, S.M. North, D.M. Wildrick, M. Olive, M. Blick, and L.C. Yeoman Transforming growth factor-alpha production and autoinduction in a colorectal carcinoma cell line (DiFi) with an amplified epidermal growth factor receptor gene Cancer Res. 53 1993 1630 1636
37. J.H. Yoon, H. Higuchi, N.W. Werneburg, S.H. Kaufmann, and G.J. Gores Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line Gastroenterology 122 2002 985 993